{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:29Z","timestamp":1740147329371,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We present an unusual case of a patient who developed four melanomas within a few months of diagnosis with human immunodeficiency virus and commencement of highly active antiretroviral therapy therapy. The patient had no previous history of melanoma, and previous skin checks were normal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 50-year-old Caucasian male drainlayer with Fitzpatrick type 2 skin presented for a routine skin examination. He had been diagnosed with human immunodeficiency virus 4\u00a0months earlier and commenced on highly active antiretroviral therapy therapy. He was found to have three melanomas (melanoma <jats:italic>in situ<\/jats:italic> stage) on excision biopsies, and when he presented for wider excisions of these sites a few weeks later, another new melanoma <jats:italic>in situ<\/jats:italic> was found. He had no other medical history of note, and no symptoms to report. He is being followed up 3-monthly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case of a human immunodeficiency virus-positive person presenting with four cutaneous melanomas\u2014occurring in both synchronous and metachronous fashion within a 4-month period\u2014is being presented both for its uniqueness and also to highlight the increased need for close skin surveillance in human immunodeficiency virus-positive patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02920-4","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:06:32Z","timestamp":1626217592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synchronous and metachronous malignant melanomas arising in a human immunodeficiency virus-positive patient after the commencement of highly active antiretroviral therapy treatment: a case report"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9601-9109","authenticated-orcid":false,"given":"Sharad P.","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hitchcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"2920_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59\u201367.","journal-title":"Lancet"},{"issue":"4","key":"2920_CR2","doi-asserted-by":"publisher","first-page":"e95096","DOI":"10.1371\/journal.pone.0095096","volume":"9","author":"CM Olsen","year":"2014","unstructured":"Olsen CM, Knight LL, Green AC. Risk of melanoma in people with HIV\/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. PLoS ONE. 2014;9(4):e95096.","journal-title":"PLoS ONE"},{"issue":"1","key":"2920_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jid.2018.07.009","volume":"139","author":"A Nosrati","year":"2019","unstructured":"Nosrati A, Yu WY, McGuire J, et\u00a0al. Outcomes and risk factors in patients with multiple primary melanomas. J Invest Dermatol. 2019;139(1):195\u2013201.","journal-title":"J Invest Dermatol"},{"key":"2920_CR4","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","volume":"20","author":"MJ Silverberg","year":"2011","unstructured":"Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, et\u00a0al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:2551\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"2920_CR5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1001\/jamadermatol.2017.1716","volume":"153","author":"MM Asgari","year":"2017","unstructured":"Asgari MM, Ray GT, Quesenberry CP Jr, Katz KA, Silverberg MJ. Association of multiple primary skin cancers with human immunodeficiency virus infection, CD4 count, and viral load. JAMA Dermatol. 2017;153(9):892\u20136.","journal-title":"JAMA Dermatol"},{"issue":"9","key":"2920_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jamadermatol.2019.1134","volume":"155","author":"M El Sharouni","year":"2019","unstructured":"El Sharouni M, Witkamp AJ, Sigurdsson V, van Diest PJ. Comparison of survival between patients with single vs multiple primary cutaneous melanomas. JAMA Dermatol. 2019;155(9):1049\u201356.","journal-title":"JAMA Dermatol"},{"key":"2920_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/bjd.14846","volume":"176","author":"LM Pardo","year":"2016","unstructured":"Pardo LM, van der Leest RJT, de Vries E, Soerjomataram I, Nijsten T, Hollestein LM. Comparing survival of patients with single or multiple primary melanoma in the Netherlands: 1994\u20132009. Br J Dermatol. 2016;176:531\u20133.","journal-title":"Br J Dermatol"},{"key":"2920_CR8","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.jid.2016.03.014","volume":"136","author":"DR Youlden","year":"2016","unstructured":"Youlden DR, Baade PD, Soyer HP, Youl PH, Kimlin MG, Aitken JF, et\u00a0al. Ten-year survival after multiple invasive melanomas is worse than after a single melanoma: a population-based study. J Invest Dermatol. 2016;136:2270\u20136.","journal-title":"J Invest Dermatol"},{"key":"2920_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella Jr","year":"1998","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et\u00a0al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853\u201360.","journal-title":"N Engl J Med"},{"key":"2920_CR10","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, et\u00a0al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374\u2013403.","journal-title":"Eur J Cancer"},{"issue":"10","key":"2920_CR11","doi-asserted-by":"publisher","first-page":"e12806","DOI":"10.1111\/dth.12806","volume":"75","author":"M Ceccarelli","year":"2019","unstructured":"Ceccarelli M, VenanziRullo E, Vaccaro M, et\u00a0al. HIV-associated psoriasis: epidemiology, pathogenesis, and management. Dermatol Ther. 2019;75(10):e12806\u2013e12806.","journal-title":"Dermatol Ther"},{"issue":"12","key":"2920_CR12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/archinternmed.2009.104","volume":"169","author":"N Crum-Cianflone","year":"2009","unstructured":"Crum-Cianflone N, Hullsiek KH, Satter E, et\u00a0al. Cutaneous malignancies among HIV-infected persons. Arch Intern Med. 2009;169(12):1130\u20138.","journal-title":"Arch Intern Med"},{"key":"2920_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/QAD.0b013e3282f47082","volume":"22","author":"JL Long","year":"2008","unstructured":"Long JL, Engels EA, Moore RD, Gebo KA. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS. 2008;22:489\u201396.","journal-title":"AIDS"},{"key":"2920_CR14","first-page":"994","volume":"5","author":"J Cebon","year":"2007","unstructured":"Cebon J, Gedye C, John T, Davis ID. Immunotherapy of advanced or metastatic melanoma. Clin Adv Hematol Oncol. 2007;5:994\u20131006.","journal-title":"Clin Adv Hematol Oncol"},{"key":"2920_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0952-7915(00)00195-3","volume":"13","author":"AN Houghton","year":"2001","unstructured":"Houghton AN, Gold JS, Blachere NE. Immunity against cancer: lessons learned from melanoma. Curr Opin Immunol. 2001;13:134\u201340.","journal-title":"Curr Opin Immunol"},{"key":"2920_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CMR.0b013e32832eabd5","volume":"19","author":"LV Kalialis","year":"2009","unstructured":"Kalialis LV, Drzewiecki KT, Klyver H. Spontaneous regression of metastases from melanoma: review of the literature. Melanoma Res. 2009;19:275\u201382.","journal-title":"Melanoma Res"},{"issue":"11","key":"2920_CR17","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/jid.2015.312","volume":"135","author":"HA Robbins","year":"2015","unstructured":"Robbins HA, Clarke CA, Arron ST, et\u00a0al. Melanoma risk and survival among organ transplant recipients. J Invest Dermatol. 2015;135(11):2657\u201365.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2920_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/bjd.15510","volume":"177","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Green AC, Nijsten T, et\u00a0al. The global burden of melanoma: results from the Global Burden of Disease Study 2015. Br J Dermatol. 2017;177(1):134\u201340.","journal-title":"Br J Dermatol"},{"key":"2920_CR19","unstructured":"U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on 2019 submission data (1999\u20132017): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; www.cdc.gov\/cancer\/dataviz, released in June 2020."},{"key":"2920_CR20","unstructured":"Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2014\u20132018. HIV Surveillance Supplemental Report 2020;25(No. 1). http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Published May 2020. Accessed 20 July 2020."},{"key":"2920_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/jnci\/djs529","volume":"105","author":"MJ Silverberg","year":"2013","unstructured":"Silverberg MJ, Leyden W, Warton EM, Quesenberry CP Jr, Engels EA, et\u00a0al. HIV infection status, immunodeficiency, and the incidence of nonmelanoma skin cancer. J Natl Cancer Inst. 2013;105:350\u201360.","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02920-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:18:24Z","timestamp":1626221904000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02920-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2920"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02920-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2021,7,14]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"367"}}